產(chǎn)品基本信息
產(chǎn)品編號(hào)：H801500
產(chǎn)品名稱：19-Hydroxyandrostendione
產(chǎn)品CAS：510-64-5
規(guī)格含量：25mg
產(chǎn)品價(jià)格：面議
聯(lián)系我們:
產(chǎn)品詳細(xì)介紹
標(biāo)準(zhǔn)品編號(hào):
H801500
名稱:
19-Hydroxyandrostendione
別名:
19-Hydroxyandrost-4-ene-3,17-dione; Androst-4-en-19-ol-3,17-dione; Androst-4-ene-3,17-dione-19-ol; NSC 74233;
CAS號(hào):
510-64-5
分子式:
C??H??O?
外觀:
白色至淡黃色固體
熔點(diǎn):
162-164°C
分子量:
302.41
儲(chǔ)存:
-20°C Freezer
溶解度:
Chloroform (Slightly), Methanol (Slightly)
種類:
Standards; Steroids; Enzyme Activators and Inhibitors;
應(yīng)用:
19-Hydroxyandrostendione is a novel substituted estrogen as aromatase inhibitor. It induces neuroendocrine trans-differentiation of prostate cancer cells via an ectopic olactory receptor.
參考文獻(xiàn)
Polan, M., et al.: J. Clin. Endocrinol. Metab., 70, 480 (1990), Kawasaki, T., et al.: Clin. Exp. Rheumatol., 18, 743, (2000), Castagnetta, L., et al.: Clin. Cancer Res., 8, 3146 (2002); Frontiers in Oncology, May 2018, vol. 8, article 162; https://doi.org/10.3389/fonc.2018.00162; Gen. Eng. and Biotech. News (https://www.genengnews.com/gen-news-highlights/could-prostate-cancer-be-treated-with-aromatherapy-in-the-future/81255862)
?您的位置：
